Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.

Authors

Yunbo Yu, Yuheng Liu, Xin Zhang, Wenyue Yang, Sencong Hou, Wenqian Yu, Feifei Zhang, Bo Yu, Zhihuang Hu, Zhenhua Wu, Shenglin Huang, Jialei Wang

Published in

Journal for immunotherapy of cancer. Volume 14. Issue 10. Oct 14, 2026. Epub Oct 14, 2026.

PMID:
42875050
Bibliographic data and abstract were imported from PubMed on 15 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.